Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Kristine Heidemeyer, Simone Cazzaniga, Letizia Dondi, Giulia Ronconi, Antonella Pedrini, Andrea Bellatreccia, Yichen Zhong, Nello Martini, Luigi Naldi
BACKGROUND: Limited data exist to predict the development of psoriatic arthritis (PsA) in psoriasis (PsO) patients OBJECTIVE: To analyze factors associated with incident PsA in PsO patients, and to develop a predictive algorithm for progression to arthritis using a full set of variables and a restricted one applicable to administrative data. METHODS: Cohort study within the PsoReal registry in Italy. Multivariable generalized linear models were used to assess factors associated with PsA and to derive a predictive model...
March 23, 2023: Journal of the American Academy of Dermatology
#2
JOURNAL ARTICLE
Michelle C Juarez, Maressa C Criscito, Akshay Pulavarty, Mary L Stevenson, John A Carucci
No abstract text is available yet for this article.
March 23, 2023: Journal of the American Academy of Dermatology
#3
JOURNAL ARTICLE
Ting Gong, Peng Zhang, Shifan Ruan, Zhixun Xiao, Wen Chen, Min Lin, Qingmei Zhong, Renwei Luo, Qiuyun Xu, Jiamei Peng, Bo Cheng, Fa Chen, Lihong Chen, Wen-Hung Chung, Chao Ji
BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening adverse drug reactions. Conventional systemic therapies are of limited efficacy and often exhibit strong side effects. OBJECTIVE: To assess the efficacy and safety of the combination treatment with a tumor necrosis factor (TNF) - α antagonist adalimumab and delineate the underlying mechanisms. METHODS: We evaluated the efficacy and safety of the combination therapy with adalimumab by comparing two treatment cohorts of SJS/TEN patients...
March 22, 2023: Journal of the American Academy of Dermatology
#4
JOURNAL ARTICLE
Ryan Ladd, Debra Keith, Shari Ochoa
No abstract text is available yet for this article.
March 21, 2023: Journal of the American Academy of Dermatology
#5
EDITORIAL
Warren R Heymann
No abstract text is available yet for this article.
March 21, 2023: Journal of the American Academy of Dermatology
#6
JOURNAL ARTICLE
Teresa Xiao, Camron Shirkhodaie, Arlene Ruiz de Luzuriaga
No abstract text is available yet for this article.
March 20, 2023: Journal of the American Academy of Dermatology
#7
JOURNAL ARTICLE
Alexander Meves, Austin Todd, Emma F Johnson
No abstract text is available yet for this article.
March 20, 2023: Journal of the American Academy of Dermatology
#8
LETTER
Romain Salle, Charbel Skayem, Camille Hua, Olivier Chosidow, Tu-Anh Duong
No abstract text is available yet for this article.
March 20, 2023: Journal of the American Academy of Dermatology
#9
JOURNAL ARTICLE
Bianca Patel, Travis W Blalock
No abstract text is available yet for this article.
March 20, 2023: Journal of the American Academy of Dermatology
#10
LETTER
Tessa M LeWitt, Christina J Walker, Maria L Espinosa, Christopher Chung, Xiaolong Alan Zhou, Joan Guitart
No abstract text is available yet for this article.
March 20, 2023: Journal of the American Academy of Dermatology
#11
JOURNAL ARTICLE
Elizabeth M Mata, Natalia Trinidad, Elliot Blue, Marissa Lobl, Dillon Clarey, Cheng Zheng, Ashley Wysong
No abstract text is available yet for this article.
March 20, 2023: Journal of the American Academy of Dermatology
#12
JOURNAL ARTICLE
Bonnie W Leung, Guihong Wan, Nga Nguyen, Hannah Rashdan, Shijia Zhang, Wenxin Chen, Sonia Cohen, Genevieve M Boland, Ryan J Sullivan, Riley M Fadden, Howard L Kaufman, Shawn G Kwatra, Nicole R LeBoeuf, Yevgeniy R Semenov
BACKGROUND: Previous studies have shown that combining immune checkpoint inhibitors (ICIs) with talimogene laherparepvec (TVEC) may improve antitumor responses. However, the risk of developing cutaneous immune-related adverse events (cirAEs) in patients treated with ICI and TVEC has not been studied. OBJECTIVE: To evaluate the differences in cirAE development between patients treated with ICI alone and both ICI and TVEC (ICI + TVEC). METHODS: Patients with cutaneous malignancy receiving ICI with or without TVEC therapy at the Massachusetts General Brigham healthcare system were included...
March 19, 2023: Journal of the American Academy of Dermatology
#13
LETTER
Elisabetta Magnaterra, Biancamaria Zuccaro, Manfredi Magliulo, Federico Venturi, Flavia Silvestri, Massimo Gola, Vincenzo De Giorgi
No abstract text is available yet for this article.
March 18, 2023: Journal of the American Academy of Dermatology
#14
LETTER
Noureddine Litaiem, Meriem Fazzani, Faten Zeglaoui
No abstract text is available yet for this article.
March 18, 2023: Journal of the American Academy of Dermatology
#15
LETTER
Bérengère Dadone-Montaudié, Henri Montaudié
No abstract text is available yet for this article.
March 17, 2023: Journal of the American Academy of Dermatology
#16
LETTER
Michelle A Pitch, Jerad M Gardner
No abstract text is available yet for this article.
March 17, 2023: Journal of the American Academy of Dermatology
#17
LETTER
Mary-Ann El Sharouni, Serigne N Lo, Richard A Scolyer, Carla H van Gils, John F Thompson
No abstract text is available yet for this article.
March 17, 2023: Journal of the American Academy of Dermatology
#18
LETTER
Raghav Tripathi, Harib H Ezaldein
No abstract text is available yet for this article.
March 17, 2023: Journal of the American Academy of Dermatology
#19
JOURNAL ARTICLE
Alyce M Kuo, Samir Kamat, Tyler J D'Ovidio, Rebecca Z Zhou, Nicole Zatorski, Nanette B Silverberg, Justine Fenner
No abstract text is available yet for this article.
March 17, 2023: Journal of the American Academy of Dermatology
#20
JOURNAL ARTICLE
Abrahim Abduelmula, Siddhartha Sood, Asfandyar Mufti, Anna Hinek, Jensen Yeung
No abstract text is available yet for this article.
March 17, 2023: Journal of the American Academy of Dermatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
